Apple Watch
Apple Watch is Apple's line of smartwatches running watchOS. The FY2026 10-K lists the current line as Series 12, Ultra 4 and SE 3. The watches work with an iPhone and track health and fitness, including FDA-cleared ECG, irregular-rhythm, sleep apnea and hypertension notifications. Apple makes its money mainly from selling the watches. Its paid add-on, Apple Fitness+ ($9.99/month), is optional, and Apple reports its revenue inside Services, not with the watches.
5 devices · 8 clearances on file · researched 2026-11-08
- Headquarters
- Cupertino, United States
- Founded
- 1976
- Ownership
- Division of Apple Inc. · AAPL
- Website
- apple.com/watch
- Focus
- fitness, heart health, sleep, recovery, women's health, medical, outdoor/navigation, sports performance
- Membership
- Apple Fitness+ · $9.99/mo · $79.99/yr · optional ↗Optional service. New subscribers get one month free, then $9.99/month or $79.99/year. Buyers of Series 12, SE 3 or Ultra 4 may get three months of Fitness+ and Apple Music. Fitness+ adds guided workouts and meditations with Apple Watch metrics shown on screen. Apple reports it inside Services, not Wearables.
- Leadership
- John Ternus CEO, Apple Inc. ↗
Tim Cook Executive Chair of the Board ↗
Kevan Parekh CFO ↗
Eddy Cue SVP Services and Health ↗ - Employees
- 167,000 (2026, Apple Inc. total, about 167,000 full-time equivalent employees at 26 Sep 2026 (parent group, not Watch only)) ↗
- Revenue
- USD 35,577,000,000 (2026, Wearables, Home and Accessories net sales category, fiscal year ended 26 Sep 2026: $35,577M, flat (FY2025 $35,686M; FY2024 $37,005M). This line also includes AirPods, Beats, Vision Pro, Apple TV, HomePod and accessories, so it is not a watch-only figure. Apple's reportable segments are geographic.) ↗
- Directory
- Apple on /companies →
1
Devices
Each device as the maker lists it; a dash means no source states the figure.
| Device | Form | Status | Sensors | Battery | Price |
|---|---|---|---|---|---|
| Apple Watch Series 12 ↗2026-09New Health Sensing System with S11 chip: background heart rate every 5 s, HRV as often as every 5 min, readiness score; up to 24 h battery; aluminum, titanium (3D-printed) and ceramic cases | watch | On sale | optical HR (Health Sensing System), electrical heart sensor (ECG), blood oxygen, temperature sensor, water temperature sensor, depth gauge (6 m), GPS (precision L1) | 1 d | $399starts at $399 (U.S.), Apple press release 2026-09-09; 42mm $399 on apple.com 2026-11-08 |
| Apple Watch Ultra 4 ↗2026-09Up to 50 h normal use (84 h Low Power Mode), up to 45 h outdoor workout tracking; satellite messaging/SOS; 5G; titanium case | watch | On sale | optical HR (Health Sensing System), electrical heart sensor (ECG), blood oxygen, temperature sensor, water temperature sensor, depth gauge (40 m), precision dual-frequency GPS | 2.08 d | $799starts at $799 (U.S.), Apple press release 2026-09-09 |
| Apple Watch SE 3 ↗2025-09Budget model: no ECG app, Blood Oxygen app or hypertension notifications; has sleep apnea notifications, sleep score, 5G; up to 18 h battery | watch | On sale | optical HR, temperature sensor (wrist temperature), accelerometer-based sleep apnea notifications, GPS | 0.75 d | $249starts at $249 (U.S.), press release 2025-09-09; apple.com shows 'Starting at $229' with education savings (2026-11-08) |
| Apple Watch Series 11 ↗2025-09Launched hypertension notifications and sleep score | watch | Discontinued | optical HR, electrical heart sensor (ECG), blood oxygen, temperature sensor, depth gauge (6 m), GPS | 1 d | $399starts at $399 (U.S.) at launch, 2025-09-09; no longer in the apple.com/watch lineup 2026-11-08 |
| Apple Watch Ultra 3 ↗2025-09Up to 42 h battery; first Apple Watch with satellite SOS (free for two years per apple.com footnote) | watch | Discontinued | optical HR, electrical heart sensor (ECG), blood oxygen, temperature sensor, water temperature sensor, depth gauge (40 m), precision dual-frequency GPS | 1.75 d | launch price not read; no longer in the apple.com/watch lineup 2026-11-08 |
2
Regulatory clearances
Health features a regulator has cleared, with the decision number.
| Feature | Device | Agency | Type | Number | Date |
|---|---|---|---|---|---|
| ECG app ↗ | Apple Watch | FDA | De Novo | DEN180044 | 2018-09 |
| irregular rhythm notification ↗ | Apple Watch | FDA | De Novo | DEN180042 | 2018-09 |
| ECG app (updated) ↗ | Apple Watch | FDA | 510(k) | K201525 | 2020-10 |
| irregular rhythm notification (IRNF app) ↗ | Apple Watch | FDA | 510(k) | K212516 | 2021-10 |
| AFib History ↗ | Apple Watch | FDA | 510(k) | K213971 | 2022-06 |
| irregular rhythm notification (IRNF) ↗ | Apple Watch | FDA | 510(k) | K231173 | 2023-07 |
| sleep apnea notification ↗ | Apple Watch | FDA | 510(k) | K240929 | 2024-09 |
| hypertension notification ↗ | Apple Watch | FDA | 510(k) | K250507 | 2025-09 |
3
Partnerships
Teams, leagues, insurers and health systems that use or resell the devices.
- 2026-09Quest Diagnostics — Users can book labs covering more than 50 biomarkers for $119 through the redesigned Health app, at about 2,000 Quest locations in the U.S. ↗
- 2026-09Klarna — Runs Apple Upgrade, the U.S. leasing program for Apple Watch (Series 12 from $11.99/month over 24 months) ↗
- 2025-05Emory Healthcare — Mac, iPhone, iPad and Apple Watch deployed across Emory Hillandale Hospital with Epic apps ↗
4
Dated facts
Launches, lawsuits, acquisitions and filings, newest first.
- 2026-11FY2026 10-K: Wearables, Home and Accessories net sales $35,577M, 'relatively flat' against FY2025 ($35,686M). Total Apple net sales $478,834M. ↗
- 2026-09Apple announced Apple Watch Series 12 and Ultra 4 with a new Health Sensing System and S11 chip, from $399 and $799 (U.S.), in stores 18 Sep 2026. ↗
- 2026-09Apple Watch Series 12 is made with 40% recycled material, including 100% recycled aluminum in aluminum cases and 100% recycled titanium in the 3D-printed titanium case. ↗
- 2025-12Apple Fitness+ expanded to 28 new markets, including Chile, Hong Kong, India, the Netherlands, Singapore and Taiwan, on 15 Dec 2025, with Japan early 2026. Apple called it the service's largest expansion since launch. ↗
- 2025-11A U.S. federal jury found Apple owes Masimo $634 million for infringing a pulse-oximetry patent. Apple said the patent expired in 2022 and that it would appeal. ↗
- 2025-09Series 11 launched hypertension notifications for Series 9 and later and Ultra 2 and later. Apple said they were validated in a study of over 2,000 participants and were expected to notify over 1 million people with undiagnosed hypertension in the first year. FDA cleared them on 11 Sep 2025 (K250507). ↗
- 2025-09Apple Watch SE 3 launched at $249 (U.S.) with sleep apnea notifications, wrist temperature, Always-On display and 5G. ↗
- 2025-08After a U.S. Customs ruling, Apple brought back a redesigned Blood Oxygen feature for some Series 9, Series 10 and Ultra 2 users in the U.S. The data is now calculated on the paired iPhone. ↗
- 2024-01After the Masimo patent dispute, U.S. sales of Apple Watch with Blood Oxygen were banned from December 2023 and again from 18 Jan 2024. Apple sold U.S. models with the feature disabled. ↗
5
Not yet confirmed
Claims seen in only one non-official place. Shown so they can be checked, not as findings.
- Judge James V. Selna rejected Apple's post-trial challenge to the $634M Masimo verdict (July 2026). Seen only in search results (macdailynews.com, idropnews.com), not fetched.
- Masimo has since become part of Danaher Corporation, and the ITC declined to review Masimo's further petitions. Both are from a search summary only.
- The context record says Apple's ECG app had De Novo decisions in 2018 and 2020. openFDA shows the 2020 decision (K201525) was a traditional 510(k); only the 2018 ones (DEN180044, DEN180042) were De Novo.
S
Sources
Retrieved 2026-11-08.
- Apple Inc. Form 10-K for fiscal 2026 (filed 2026-11-03) — SEC EDGAR
- Apple filing index — SEC
- Apple Watch — Apple
- Compare Apple Watch models — Apple
- Apple Watch Series 12 — Apple
- Apple Watch Ultra 4 — Apple
- Apple Watch SE 3 — Apple
- Apple Fitness+ — Apple
- Apple Leadership — Apple
- Introducing Apple Watch Series 12 — Apple Newsroom
- Apple unveils Apple Watch Ultra 4 — Apple Newsroom
- Apple debuts Apple Watch Series 11 — Apple Newsroom
- Apple introduces Apple Watch SE 3 — Apple Newsroom
- An update on Blood Oxygen for Apple Watch in the U.S. — Apple Newsroom
- Apple Fitness+ expands to 28 new markets — Apple Newsroom
- Apple products transform care at Emory Healthcare — Apple Newsroom
- Apple reports fourth quarter results (FY2026) — Apple Newsroom
- openFDA 510(k)/De Novo decisions, applicant Apple Inc. (12 results) — U.S. FDA
- Apple Hit With $634 Million Verdict in Apple Watch Blood Oxygen Patent Lawsuit — MacRumors